2.995PLN+4.17%Mkt Cap: 43.70M $P/E: —Today
Synthaverse S.A., a pharmaceutical company, manufactures and sells medicinal preparations, medical devices, and laboratory reagents for use in oncology, gynecology, hematology, immunology, and related therapeutic areas i…
Industry Peers
Biotechnology$130.23BUSDP/E 32.1
$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$61.34BUSDP/E 39.8
$45.95BUSDP/E 19.6
$46.01BUSD
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.26BUSDP/E 26.6
$17.03BUSDP/E 20.0
$16.41BUSD
$13.48BUSDP/E 17.1
$13.42BUSDP/E 187.4
$12.87BUSDP/E 264.5
Key Statistics
Company
Market Cap43.70M $
Enterprise Value76.02M $
Revenue (TTM)10.69M $
Gross Profit5.97M $
Net Income (TTM)-5.05M $
Revenue/Share0.1449 USD
Last Price2.995 PLN
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees214
CountryPL
SectorHealthcare
IndustryBiotechnology
ISINPLBMDLB00018
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-24.45
EV/Revenue7.11
P/S4.03
P/B1.84
EPS (TTM)-0.30
EPS (Forward)—
52W Range
2.60016% of range5.050
52W High5.050 PLN
52W Low2.600 PLN
Profitability
Gross Margin56.09%
Oper. Margin-5.15%
EBITDA Margin-29.10%
Profit Margin-47.45%
ROE-15.99%
ROA-6.55%
Growth
Revenue Growth1.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF3.00M $
CapEx (TTM)7.10M $
FCF Margin-185.92%
FCF Yield-45.46%
Net Debt20.85M $
Net Debt/EBITDA-6.70
Balance Sheet
Debt/Equity0.68
Current Ratio0.88
Quick Ratio0.15
Book Value/Sh1.600 PLN
Cash/Share0.0380 PLN
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 PLN
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.57.61M
Float48.42M
Insiders39.03%
Institutions6.83%
Technical
SMA 502.818 (+6.3%)
SMA 2003.440 (-12.9%)
Beta0.01
S&P 52W Chg18.16%
Avg Vol (30d)54.79K
Avg Vol (10d)47.99K
Technical Indicators
RSI (14)49.5
MACD0.0272
MACD Signal0.0354
MACD Hist.-0.0082
BB Upper3.095 PLN
BB Middle2.890 PLN
BB Lower2.684 PLN
BB Width14.22%
ATR (14)0.0856 PLN
Vol Ratio (20d)0.60x